Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
europe blog main
3
×
financing
3
×
life sciences
national blog main
national top stories
bms
bristol-myers squibb
cancer
europe top stories
kite
national
novartis
otsuka pharmaceutical
startups
accent therapeutics
acquisitions
aducanumab
advanced therapies
alzheimer's disease
amblyotech
arvelle
asklepios biopharmaceutical
atmp
avexis
bioeurope
biogen
biomarin pharmaceutical
bioprocess insider
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
brammer bio
c. greg guyer
car-t
car-t chimeric antigen receptor
cara therapeutics
catalent
What
access
activity
advanced
amsterdam
approvals
bio
biogen
board
bristol
capacity
car
cell
clamped
consolidation
covid
crispr
delays
developing
economic
european
falcon
fast
fda
firm
focus
focused
fund
gene
healthcare
including
investment
ipo
isn’t
largest
life
lot
lsp
medicines
milestones
new
Language
unset
Current search:
financing
×
biotech
×
" europe blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019